Vice President, Medical Affairs Rare Diseases
Pubblicato il 12-08-2026 - Recordati in Turbigo
Job Purpose
The VP, Medical Affairs, Rare Diseases BU will provide strategic medical leadership and oversight to support the continued growth of the Rare Diseases (RRD) portfolio. The role will champion patient‑centricity as a key driver of business decisions and act as a spokesperson for Recordati within the scientific community, collaborating closely with cross‑functional colleagues globally—clinical development, regulatory, commercial, and business development.
Overall Objectives
- Provide strategic medical leadership and oversight across Rare Diseases to shape and execute global medical affairs strategies, working closely with commercial and business development colleagues.
- Ensure proactive, timely and highly qualified medical input is provided within cross‑functional teams.
- Ensure RRD Medical Affairs Teams adopt consistent and efficient processes across geographies (e.g., in terms of systems, tools, KPIs) and foster best‑practice sharing.
- Ensure the effective and compliant communication of scientific and medical information while generating robust evidence to enhance product value and safety, ultimately contributing to the Rare Diseases portfolio growth.
- Ensure all medical activities adhere to ethical standards, corporate governance and international regulatory frameworks.
- Provide strategic medical leadership across the Rare Diseases BU, ensuring robust, patient‑centric medical affairs strategies that support the BU’s growth and innovation goals.
Key Responsibilities
Medical Affairs Strategy and Execution
- Develop and implement integrated Medical Affairs strategies and plans for rare diseases products.
- Lead the creation of Integrated Evidence Plans (IEPs) and ensure alignment with clinical development, regulatory, market access and commercial.
Medical Leadership & Lifecycle Management
- Provide medical leadership and expertise to guide medical activities across the Business Unit.
- Provide medical input into BD assessments and lifecycle managemen